IL-2R alpha (CD25) [Basiliximab] Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-IL-2R alpha (CD25) [Basiliximab] antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IL-2R alpha (CD25) [Basiliximab] |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | Protein A purified |
| Size | 0.2 mg |
| Concentration | n/a |
| Applications | Flow Cytometry (FC/FACS), Block, Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Recognizes the human IL-2R alpha (CD25). Recombinant monoclonal antibody to IL-2R alpha (CD25). Manufactured using a Recombinant Platform with variable regions (i.e. specificity) from the therapeutic antibody Basiliximab. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
| Immunogen | n/a |
| Other Names | [Interleukin-2 receptor subunit alpha; IL-2 receptor subunit alpha; IL-2R subunit alpha; IL-2-RA; IL2-RA; TAC antigen; p55; CD25.], [IL2RA; IL2RA; p55; CD25; IL2R; IMD41; TCGFR; IDDM10; IL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA] |
| Gene, Accession # | [IL-2R alpha], Gene ID: 3559 |
| Catalog # | MBS488160 |
| Price | $425 |
| Order / More Info | IL-2R alpha (CD25) [Basiliximab] Antibody from MYBIOSOURCE INC. |
| Product Specific References | Kovarik et al. Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts. Transplantation. 1997 Dec 27; 64(12):1701-5. PMID:9422405 |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies